Pulmonx Corporation

US$2.56As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:LUNGHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (37.18%)
Div yield —
ROE (90.31%)
Medical Devices
Beta (5Y) 0.17
PE TTM —
TSR TTM 28.00%
Mkt cap US$109.9M
ROIC (23.78%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.28
28.23%
(28.13%)
Hold 10|11|1|0|7
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.03
0.03
0.03
0.03
13.85%
16.94%
25.54%
18.68%
Revenue$M
8.351
8.735
8.781
9.112
4.45%
5.47%
7.14%
13.81%
Peers (US$109.9M)
Cap (US$)
PE
121.9M
—
110.5M
—
Capital
TTM
5Y
10Y
Leveragex
0.834
—
—
EBIT/Intx
0.694
0.245
0.227
Own earn%
(137.81)
30.92
42.15
Sh yield%
13.96
16.27
20.49
Owners
Insiders/Inst%
8.27
29.80
Short interest%
2.42
SBC / revenue%
2.35
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
26–34
$1 testx
—
Incr. ROIC%
7